|
US5585344A
(en)
|
1984-03-19 |
1996-12-17 |
The Rockefeller University |
Liver-derived receptors for advanced glycosylation endproducts and uses thereof
|
|
US4774321A
(en)
|
1986-12-01 |
1988-09-27 |
Massachusetts Institute Of Technology |
DP100 EGF and insulin-binding protein from Drosophila cells
|
|
ATE90690T1
(de)
|
1987-04-06 |
1993-07-15 |
Celtrix Pharma |
Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung.
|
|
US5200509A
(en)
|
1987-04-06 |
1993-04-06 |
Celtrix Pharmaceuticals, Inc. |
Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
|
|
WO1989006692A1
(en)
|
1988-01-12 |
1989-07-27 |
Genentech, Inc. |
Method of treating tumor cells by inhibiting growth factor receptor function
|
|
GB8826451D0
(en)
|
1988-11-11 |
1988-12-14 |
Sandoz Ltd |
Improvements in/relating to organic compounds
|
|
IL92816A0
(en)
|
1988-12-22 |
1990-09-17 |
Biogrowth Inc |
Recombinant dna molecules,hosts,processes and human somatomedin carrier protein-like polypeptides
|
|
US5571714A
(en)
|
1988-12-22 |
1996-11-05 |
Celtrix Pharmaceuticals, Inc. |
Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use
|
|
US5705157A
(en)
|
1989-07-27 |
1998-01-06 |
The Trustees Of The University Of Pennsylvania |
Methods of treating cancerous cells with anti-receptor antibodies
|
|
US5977307A
(en)
|
1989-09-07 |
1999-11-02 |
Alkermes, Inc. |
Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
|
|
JPH06503711A
(ja)
|
1990-08-28 |
1994-04-28 |
カイロン コーポレイション |
新規インシュリン様成長因子結合タンパク質（ｉｇｆｂｐ―４）
|
|
AU661533B2
(en)
|
1992-01-20 |
1995-07-27 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
US5262308A
(en)
|
1992-01-28 |
1993-11-16 |
Thomas Jefferson University |
Cell lines which constitutively express IGF-1 and IGF-1 R
|
|
US5597563A
(en)
|
1992-09-04 |
1997-01-28 |
Beschorner; William E. |
Method induction of antigen-specific immune tolerance
|
|
US5869337A
(en)
|
1993-02-12 |
1999-02-09 |
President And Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
|
JPH08508409A
(ja)
|
1993-04-06 |
1996-09-10 |
シーダーズ − サイナイ メディカル センター |
変異インスリン様増殖因子▲ｉ▼受容体サブユニットおよびそれらの使用方法
|
|
WO1995019570A1
(en)
|
1994-01-14 |
1995-07-20 |
Genentech, Inc. |
Antagonists to insulin receptor tyrosine kinase inhibitor
|
|
US5532159A
(en)
|
1994-04-01 |
1996-07-02 |
The Ohio State University |
Monoclonal antibody to canine placental oncofetal protein for detecting cancer
|
|
US5597700A
(en)
|
1994-04-28 |
1997-01-28 |
California Research, Llc |
Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
|
|
ES2150573T3
(es)
|
1994-06-24 |
2000-12-01 |
Vladimir P Torchilin |
Composicion que contiene autoanticuerpos para la terapia y profilaxis tumorales.
|
|
US5939269A
(en)
|
1994-12-28 |
1999-08-17 |
The Regents Of The University Of California |
Antagonists to insulin receptor tyrosine kinase inhibitor
|
|
ATE446955T1
(de)
|
1995-03-30 |
2009-11-15 |
Pfizer Prod Inc |
Chinazolinone derivate
|
|
CA2222231A1
(en)
|
1995-06-07 |
1996-12-19 |
Imclone Systems Incorporated |
Antibody and antibody fragments for inhibiting the growth of tumors
|
|
US6084085A
(en)
|
1995-11-14 |
2000-07-04 |
Thomas Jefferson University |
Inducing resistance to tumor growth with soluble IGF-1 receptor
|
|
AUPN999096A0
(en)
|
1996-05-22 |
1996-06-13 |
Northstar Biologicals Pty Ltd |
Peptides, antibodies, vaccines & uses thereof
|
|
US5798266A
(en)
|
1996-08-27 |
1998-08-25 |
K-Quay Enterprises, Llc |
Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
|
|
US6071891A
(en)
|
1996-11-22 |
2000-06-06 |
Regents Of The University Of Minnesota |
Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells composition
|
|
US5968895A
(en)
*
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
|
NZ517497A
(en)
*
|
1997-08-15 |
2004-11-26 |
Cephalon Inc |
The synergistic effect of tyrosine kinase inhibitors and chemical castration agents in the treatment of prostate cancer
|
|
ZA200007412B
(en)
|
1998-05-15 |
2002-03-12 |
Imclone Systems Inc |
Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases.
|
|
US6875741B2
(en)
|
1998-09-02 |
2005-04-05 |
Renuka Pillutla |
Insulin and IGF-1 receptor agonists and antagonists
|
|
KR100731820B1
(ko)
|
1998-10-05 |
2007-06-25 |
파멕사 에이/에스 |
치료적 백신화를 위한 새로운 방법
|
|
EP1006184A1
(en)
|
1998-12-03 |
2000-06-07 |
F. Hoffmann-La Roche Ag |
IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof
|
|
US6316462B1
(en)
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
|
AU2001264946A1
(en)
|
2000-05-24 |
2001-12-03 |
Imclone Systems Incorporated |
Bispecific immunoglobulin-like antigen binding proteins and method of production
|
|
US7329745B2
(en)
|
2000-06-13 |
2008-02-12 |
City Of Hope |
Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
|
|
US20030165502A1
(en)
|
2000-06-13 |
2003-09-04 |
City Of Hope |
Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
|
|
EP1295939A4
(en)
|
2000-06-15 |
2005-02-02 |
Kyowa Hakko Kogyo Kk |
INSULIN SIMILAR GROWTH FACTOR BINDING PROTEIN
|
|
US8153121B2
(en)
|
2000-10-06 |
2012-04-10 |
Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center |
Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders
|
|
NZ527302A
(en)
|
2001-01-05 |
2006-10-27 |
Abgenix Inc |
Antibodies to insulin-like growth factor I receptor
|
|
CA2439735A1
(en)
|
2001-03-14 |
2002-09-19 |
Genentech, Inc. |
Igf antagonist peptides
|
|
WO2002087618A1
(en)
|
2001-04-27 |
2002-11-07 |
Takeda Chemical Industries, Ltd. |
Preventive/therapeutic method for cancer
|
|
US7666414B2
(en)
*
|
2001-06-01 |
2010-02-23 |
Cornell Research Foundation, Inc. |
Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen
|
|
US20040214898A1
(en)
*
|
2001-11-29 |
2004-10-28 |
Steiner Mitchell S. |
Methods for treating hot flashes
|
|
ES2283759T3
(es)
|
2002-01-18 |
2007-11-01 |
Pierre Fabre Medicament |
Anticuerpos anti-igf-ir y sus aplicaciones.
|
|
US7553485B2
(en)
*
|
2002-01-18 |
2009-06-30 |
Pierre Fabre Medicament |
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
|
|
US7241444B2
(en)
|
2002-01-18 |
2007-07-10 |
Pierre Fabre Medicament |
Anti-IGF-IR antibodies and uses thereof
|
|
MXPA04011624A
(es)
|
2002-05-24 |
2005-03-07 |
Schering Corp |
Anticuerpo neutralizante humano anti-igfr.
|
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
US8034904B2
(en)
|
2002-06-14 |
2011-10-11 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
CN1678634A
(zh)
|
2002-06-28 |
2005-10-05 |
多曼蒂斯有限公司 |
免疫球蛋白单个变体抗原结合区及其特异性构建体
|
|
KR101115797B1
(ko)
|
2002-08-01 |
2012-07-27 |
이뮤노메딕스, 인코오포레이티드 |
알파 태아 단백질 Ｉｍｍｕ31 항체 및 융합단백질, 및이들의 이용 방법
|
|
US20040102360A1
(en)
|
2002-10-30 |
2004-05-27 |
Barnett Stanley F. |
Combination therapy
|
|
KR20050109489A
(ko)
|
2003-02-13 |
2005-11-21 |
화이자 프로덕츠 인크. |
항-인슐린양 성장인자 ｉ 수용체 항체의 용도
|
|
BRPI0408317A
(pt)
|
2003-03-14 |
2006-03-07 |
Pharmacia Corp |
anticorpos do receptor de igf-i para o tratamento de cáncer
|
|
CA2519113C
(en)
|
2003-04-02 |
2012-06-05 |
F. Hoffmann-La Roche Ag |
Antibodies against insulin-like growth factor i receptor and uses thereof
|
|
EP2365001A3
(en)
*
|
2003-05-01 |
2012-03-28 |
Imclone LLC |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
|
AR046071A1
(es)
|
2003-07-10 |
2005-11-23 |
Hoffmann La Roche |
Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
|
|
CA2534898A1
(en)
|
2003-08-08 |
2005-02-17 |
Immunomedics, Inc. |
Bispecific antibodies for inducing apoptosis of tumor and diseased cells
|
|
CN1835975B
(zh)
|
2003-08-13 |
2012-11-21 |
辉瑞产品公司 |
经修饰的人类igf-1r抗体
|
|
EP1671647A1
(en)
|
2003-09-24 |
2006-06-21 |
Kyowa Hakko Kogyo Co., Ltd. |
Medicament for treating cancer
|
|
AR046639A1
(es)
|
2003-11-21 |
2005-12-14 |
Schering Corp |
Combinaciones terapeuticas de anticuerpo anti- igfr1
|
|
US20050164970A1
(en)
*
|
2003-12-22 |
2005-07-28 |
University Of Kansas Medical Center |
Method for treating prostate cancer using siRNA duplex for androgen receptor
|
|
WO2005082415A2
(en)
|
2004-02-25 |
2005-09-09 |
Dana Farber Cancer Institute, Inc. |
Inhibitors of insulin-like growth factor receptor-1 for inhibiting tumor cell growth
|
|
ES2387809T3
(es)
|
2004-03-19 |
2012-10-02 |
Imclone Llc |
Anticuerpo frente al receptor del factor de crecimiento epidérmico humano
|
|
CN101014365B
(zh)
|
2004-07-16 |
2011-04-13 |
辉瑞产品公司 |
使用抗-igf-1r抗体联合治疗非血液的恶性肿瘤
|
|
EP1786918A4
(en)
|
2004-07-17 |
2009-02-11 |
Imclone Systems Inc |
NEW BISPECIFIC ANTIBODY TETRAVALENT
|
|
FR2873699B1
(fr)
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
|
US20070010537A1
(en)
*
|
2004-08-20 |
2007-01-11 |
Kazumasa Hamamura |
Fused pyramidine derivative and use thereof
|
|
EP2281841A3
(en)
|
2004-12-03 |
2013-10-23 |
Merck Sharp & Dohme Corp. |
Biomarkers for pre-selection of patients for anti-IGF1R therapy
|
|
US20060134172A1
(en)
|
2004-12-21 |
2006-06-22 |
Alcon, Inc. |
Agents which regulate, inhibit, or modulate the activity and/or expression of lysyl oxidase (LOX) and LOX-like proteases as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
|
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
|
EA200702239A1
(ru)
|
2005-04-15 |
2008-10-30 |
Иммьюноджен, Инк. |
Уничтожение гетерогенной или смешанной клеточной популяции в опухолях
|
|
CA2678008C
(en)
*
|
2005-06-17 |
2013-07-30 |
Imclone Systems Incorporated |
Methods of treating a secondary bone tumor with anti-pdgfralpha antibodies
|
|
WO2007000328A1
(en)
|
2005-06-27 |
2007-01-04 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof
|
|
US20070009970A1
(en)
|
2005-07-08 |
2007-01-11 |
Predicant Biosciences, Inc. |
Biological patterns for diagnosis and treatment of cancer
|
|
FR2888850B1
(fr)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
|
AU2006290433B2
(en)
|
2005-08-26 |
2012-06-07 |
Roche Glycart Ag |
Modified antigen binding molecules with altered cell signaling activity
|
|
PL1979001T3
(pl)
|
2005-12-13 |
2012-09-28 |
Medimmune Ltd |
Białka wiążące specyficzne dla insulinopodobnych czynników wzrostu i ich zastosowania
|